Predict your next investment

Vaxxas company logo
HEALTHCARE | Biotechnology
vaxxas.com

See what CB Insights has to offer

Founded Year

2011

Stage

Grant - II | Alive

Total Raised

$58.42M

Last Raised

$22M | 1 yr ago

About Vaxxas

Vaxxas is a biotechnology company focused on enhancing the performance of existing vaccines with its Nanopatch technology platform. Vaxxas' Nanopatch contains an ultra-high density array of projections – invisible to the naked human eye – that are dry-coated with vaccine. Application of the Nanopatch to the skin is pain free and rapidly delivers the vaccine to the abundant immune cell population immediately below the skin surface. In a wide range of preclinical studies, Nanopatch delivery of vaccine achieves equivalent protective immunity as the needle and syringe – but with only 1/100th of the dose. It has also been shown that Vaxxas' proprietary dry-coating technology can eliminate the need for vaccine refrigeration during storage and transportation – removing the resource burden of maintaining the "cold chain." Leveraging both the potent immunogenic response and thermostability, Vaxxas is applying its technology to improve the performance of vaccines, with initial applications targeting infectious disease and oncology.

Vaxxas Headquarter Location

Suite 13.02, Level 13 179 Elizabeth Street

Sydney, New South Wales, 2000,

Australia

Latest Vaxxas News

Vaccine Delivery Devices Market is Expected to Represent a Value of Over US$ 4,000 Mn by 2031 End

Jan 10, 2022

Search jobs 10-Jan-2022 Vaccine Delivery Devices Market is Expected to Represent a Value of Over US$ 4,000 Mn by 2031 End 250 Pages Vaccine Delivery Devices Market Survey by Fact MR, A Leading Business and Competitive Intelligence Provider According to Fact MR’s recent market research, sales of Vaccine Delivery Devices to swell at propelled CAGR through 2031, as investment towards expansion of healthcare infrastructure continues rising. The goal of the survey is uncover growth opportunities, key trends, growth drivers, and challenges. It also provides recommendations to assist businesses in preparing for unforeseen challenges. Focus on improving overall patient care will remain a chief growth driver. Besides this, Vaccine Delivery Devices market will continue gaining from increasing willingness among patients and families to spend on advanced healthcare. To remain ‘ahead’ of your competitors, request for a sample –  https://www.factmr.com/connectus/sample?flag=S&rep_id=178   Growing prevalence of medical diseases and infections is projected to rev up demand for vaccine devices in the healthcare sector. Manufacturers are increasingly witnessing demand for vaccine delivery devices due to increase in number of diabetic patients globally. Fact.MR has recently compiled a report, which reveals that the vaccine delivery devices market globally is projected to reflect an impressive CAGR over the forecast period, 2017 – 2022. The market study done by Fact.MR gives exclusive information about how the market will grow. The study identifies crucial trends that are determining the growth of Vaccine Delivery Devices market. This newly published report sheds light on vital dynamics, such as the drivers, restraints, and opportunities for key market players as well as emerging players associated with the production and supply. The latest report by Fact.MR provides detailed Market Analysis of Vaccine Delivery Devices The report offers actionable and valuable market insights of Vaccine Delivery Devices. The latest report by Fact.MR provides details on the present scenario of the market across various regions along with the historic data and forecast of the market. The report also includes information on the sales and demand of Vaccine Delivery Devices Market across various industries and regions Market Taxonomy Full Access of this Exclusive Report is Available at-  https://www.factmr.com/checkout/178 Market Players Leading players in the global market of vaccine delivery devices are PharmaJet, Inc, Becton Dickinson & Company, Vaxxas Pty. Ltd, Valeritas Holdings, Inc, Schott AG, Gerresheimer AG, 3M Company, and Antares Pharma, Inc. Factors Propelling Global Market Growth Growing need for vaccination for treatment of various medical diseases and infections has led to an upsurge in demand for vaccine delivery devices globally. In a report published by the CDC, order to protect from diseases and infections such as meningitis, hepatitis A, and hepatitis B, and influenza immunization should be done during the birth, adolescence and adulthood period. Increasing prevalence of type 1 diabetes and type 2 diabetes among the adult and geriatric population has led to a surge in demand for the vaccine delivery devices in the healthcare sector. Type 2 diabetic patients are prescribed insulin doses such as Lantus and Novorapid by the healthcare professionals. Increasing use of insulin among diabetic patients has led to surge in demand for vaccine devices globally. These factors are expected to contribute towards the global market growth of vaccine delivery devices significantly during the projected period. Moreover, healthcare manufacturers are increasingly integrating enhanced technology to offer painless vaccine delivery devices. Recently published news update, a new device known as ‘Microneedle Patches’ is developed, which has needle-free attributes and injects a dose of vaccine within fraction of seconds. These factors are projected to impact the global market growth of vaccine delivery device positively throughout 2022. Read More Trending Reports of Fact.MR- Report Benefits & Key Questions Answered Vaccine Delivery Devices Category and segment level analysis: Fact MR provides a detailed analysis of the factors influencing sales growth across key segments. It highlights key growth drivers and provides useful information for identifying sales prospects at the regional and local level. Vaccine Delivery Devices Historical volume analysis: The report provides a comparison of Vaccine Delivery Devices’s historical sales and projected sales performance for 2021-2031. Vaccine Delivery Devices Manufacturing trend analysis: The report offers a detailed analysis of manufacturing trends in the Vaccine Delivery Devices market. It carefully gauges the impact of changing healthcare needs of key demographics globally Vaccine Delivery Devices Consumption by demographics: The report investigates consumer behavior affecting Vaccine Delivery Devices demand outlook for the assessment period. Effect of their keenness for digital trends on Vaccine Delivery Devices market is carefully analyzed Post COVID consumer spending on Vaccine Delivery Devices: Healthcare industry has been largely influenced by COVID-19 pandemic. The Fact MR Market survey analyzed consumer spending post COVID-19. It assesses how current trends that will influence expenditure on healthcare services, thus affecting Vaccine Delivery Devices market growth. More Valuable Insights on Vaccine Delivery Devices Market Fact.MR, in its new report, offers an unbiased Market Analysis of Vaccine Delivery Devices, Sales and Demand of Vaccine Delivery Devices, analyzing forecast statistics through 2019 and beyond. The study reveals growth projections on the basis of various criteria. Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain: Shower Chairs Market  – Global Industry Analysis and Opportunity Assessment 2021 – 2031 Infrared Thermometer Market  – Global Industry Analysis and Opportunity Assessment 2021 – 2031 About Fact.MR Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner. Contact:

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Vaxxas

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Vaxxas is included in 3 Expert Collections, including Medical Devices.

M

Medical Devices

7,889 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

B

Biopharma Tech

5,238 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

C

Cancer

3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

Vaxxas Patents

Vaxxas has filed 17 patents.

The 3 most popular patent topics include:

  • Drug delivery devices
  • Medical equipment
  • Vaccines
patents chart

Application Date

Grant Date

Title

Related Topics

Status

12/20/2017

12/28/2021

Drug delivery devices, Dosage forms, Vaccines, Fluid dynamics, Biotechnology

Grant

Application Date

12/20/2017

Grant Date

12/28/2021

Title

Related Topics

Drug delivery devices, Dosage forms, Vaccines, Fluid dynamics, Biotechnology

Status

Grant

Vaxxas Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Vaxxas Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.